Author
Listed:
- Madeleine L. M. Hardy
(Discipline of Physiology, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney 2006, Australia)
- Margot L. Day
(Discipline of Physiology, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney 2006, Australia
M.L.D. and M.B.M. are joint senior authors.)
- Michael B. Morris
(Discipline of Physiology, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney 2006, Australia
M.L.D. and M.B.M. are joint senior authors.)
Abstract
Oocytes and preimplantation embryos require careful regulation of the redox environment for optimal development both in vivo and in vitro . Reactive oxygen species (ROS) are generated throughout development as a result of cellular metabolism and enzyme reactions. ROS production can result in (i) oxidative eustress, where ROS are helpful signalling molecules with beneficial physiological functions and where the redox state of the cell is maintained within homeostatic range by a closely coupled system of antioxidants and antioxidant enzymes, or (ii) oxidative distress, where excess ROS are deleterious and impair normal cellular function. in vitro culture of embryos exacerbates ROS production due to a range of issues including culture-medium composition and laboratory culture conditions. This increase in ROS can be detrimental not only to assisted reproductive success rates but can also result in epigenetic and genetic changes in the embryo, resulting in transgenerational effects. This review examines the effects of oxidative stress in the oocyte and preimplantation embryo in both the in vivo and in vitro environment, identifies mechanisms responsible for oxidative stress in the oocyte/embryo in culture and approaches to reduce these problems, and briefly examines the potential impacts on future generations.
Suggested Citation
Madeleine L. M. Hardy & Margot L. Day & Michael B. Morris, 2021.
"Redox Regulation and Oxidative Stress in Mammalian Oocytes and Embryos Developed In Vivo and In Vitro,"
IJERPH, MDPI, vol. 18(21), pages 1-27, October.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:21:p:11374-:d:667750
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:21:p:11374-:d:667750. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.